| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 07/02/2003 | EP1322317A1 Compositions and methods for prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with compositions comprising unfractionated cellular proteins |
| 07/02/2003 | EP1322287A2 Microparticles for delivery of the heterologous nucleic acids |
| 07/02/2003 | EP1292249A4 Tissue engineered stents |
| 07/02/2003 | EP1285057A4 Isolation of mesenchymal stem cells and use thereof |
| 07/02/2003 | EP1227825A4 Isolation and expansion of human marrow stromal cells |
| 07/02/2003 | EP1210346B1 New active marine alkaloids |
| 07/02/2003 | EP1143994B1 Use of apoptosis inducing agents in the preparation of a medicament for the treatment of (auto)immune diseases |
| 07/02/2003 | EP1021523A4 Liver regeneration using pancreas cells |
| 07/02/2003 | EP0879282B1 Immunotherapy using cytotoxic t lymphocytes (ctl) |
| 07/02/2003 | EP0826043B1 Methods for modulating t cell survival by modulating bcl-xl protein level |
| 07/02/2003 | EP0781343B1 Retroviral vector hybrids and the use thereof for gene transfer |
| 07/02/2003 | EP0732875B1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
| 07/02/2003 | CN1427891A Anti-EGFRvIII scFv with improved cytotoxi city and yield, immunotoxins based thereon, and methods of use thereof |
| 07/02/2003 | CN1427889A Hybrid cells obtainable from antigen presenting cells |
| 07/02/2003 | CN1427887A Pluripotent cells comprising allogenic nucleus and mitochondria |
| 07/02/2003 | CN1427886A Spray-dried microbial cells |
| 07/02/2003 | CN1427726A Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy |
| 07/02/2003 | CN1426800A Snake poison capsule for treating lung cancer and its preparation method |
| 07/02/2003 | CN1113241C Method for sorting leucocyte |
| 07/02/2003 | CN1113099C New carrier for gene treatment |
| 07/02/2003 | CN1112931C Anti-stress drugs and functional foods having anti-stress effects |
| 07/01/2003 | US6586582 Human GABA receptor proteins and polynucleotides encoding the same |
| 07/01/2003 | US6586404 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 07/01/2003 | US6586394 Tissue-derived tumor growth inhibitor |
| 07/01/2003 | US6586393 Cyclic peptide antibiotics from Actinomadura sp. of given formula; selective inhibitory activity against E. coli RNA polymerase; use treating infections |
| 07/01/2003 | US6586392 Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins |
| 07/01/2003 | US6586192 Compositions and methods for use in affecting hematopoietic stem cell populations in mammals |
| 07/01/2003 | US6586185 Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances |
| 07/01/2003 | US6585969 Non-viable keratinocyte cell composition or lysate for promoting wound healing |
| 07/01/2003 | US6585968 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
| 06/26/2003 | WO2003052085A1 Dermal replacement prepared from mesenchymal cells of hair follicle |
| 06/26/2003 | WO2003052084A2 Cell constructs cultured in vitro, preparation and uses |
| 06/26/2003 | WO2003052052A2 Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor |
| 06/26/2003 | WO2003052051A2 Adeno-associated virus (aav) serotype 8 sequences |
| 06/26/2003 | WO2003051831A2 Protease inhibitors of the coagulation cascade isolated from dysidea sponges |
| 06/26/2003 | WO2003051454A2 Methods for particle-assisted polynucleotide immunization using a pulsed electric field |
| 06/26/2003 | WO2003051396A1 Treating vascular disease by inhibiting myeloid differentiation factor 88 |
| 06/26/2003 | WO2003051379A1 Outer membrane vesicles from gram negative bacteria and use as a vaccine |
| 06/26/2003 | WO2003051378A2 Pharmaceutical composition for topical treatment of skin disorders and skin wounds |
| 06/26/2003 | WO2003051354A1 Method of treatment |
| 06/26/2003 | WO2003030820A3 Pseudopterosin compounds of symbiodinium spp isolated from pseudopterogorgia elisabethae |
| 06/26/2003 | WO2003024989A3 Activation and expansion of cells |
| 06/26/2003 | WO2002080945A3 Methods for treating the inflammatory component of a brain disorder |
| 06/26/2003 | WO2002004493A3 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 06/26/2003 | US20030119907 Accelerating uncoupled respiration and proton leak of the inner membrane of mitochondria which are induced by uncoupling proteins usingcoupled isomerized highly unsaturated fatty acids |
| 06/26/2003 | US20030119781 Hyaluronic acid in soft gel form |
| 06/26/2003 | US20030119774 Compositions and methods for stimulating an immune response |
| 06/26/2003 | US20030119187 Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 06/26/2003 | US20030119185 Activation and expansion of cells |
| 06/26/2003 | US20030119182 Immunotherapy; genetic engineering; anticancer agents |
| 06/26/2003 | US20030119080 Strategies for the identification and isolation of cancer stem cells and non-cancerous stem cells |
| 06/26/2003 | US20030119076 B7-like polynucleotides, polypeptides, and antibodies |
| 06/26/2003 | US20030119070 Complexing ligand, peptide ; displacement of one ligand with another |
| 06/26/2003 | US20030119033 Immunoassay using antibodies |
| 06/26/2003 | US20030118666 Injectable solution containing a shark-derived chondroitin sulfate iron colloid |
| 06/26/2003 | US20030118663 Protein containing mori folium, soybean and dried powder of bonito or bonito liver, polysaccharide containing lycii fructus and mori folium and a carrier |
| 06/26/2003 | US20030118662 Treatment of high blood pressure, stroke, obesity, and various other disorders |
| 06/26/2003 | US20030118661 Soft-shelled turtle, ageratum, ginseng and glucose; aging resistance |
| 06/26/2003 | US20030118611 Epitopes confirmed to be recognized by T-cells derived from herpetic lesions or uterine cervix; vaccination |
| 06/26/2003 | US20030118602 Peptides and immunologically functional variants thereof which are immunogenic epitopes recognized by CD8+ class I major histocompatibility complex restricted cytotoxic T-lymphocytes of patients harboring latent human cytomegalovirus infection |
| 06/26/2003 | US20030118600 Transfer compounds, production and use thereof |
| 06/26/2003 | US20030118571 Oral administration of lactobacillus for the maintenance of health in women during pregnancy and at other life stages, to reduce the risk of urogenital diseases |
| 06/26/2003 | US20030118570 Vectors for tissue-specific replication |
| 06/26/2003 | US20030118567 Cell-based therapy for the pulmonary system |
| 06/26/2003 | US20030118566 Differentiating the obtained central nervous system (CNS) stem cells by culturing stems cells in vitro in differentiation medium containing fibroblast growth factor 8 and glial cell line derived neurotrophic factor, transplanting them into CNS |
| 06/26/2003 | US20030118565 Treatment of muscular dystrophy with cord blood cells |
| 06/26/2003 | US20030118563 Materials and methods for repair of tissue |
| 06/26/2003 | US20030118559 Contacting the bodily fluid of a patient with renal tubule cells outside of the kidney for treating systemic inflammatory response syndrome (SIRS) |
| 06/26/2003 | US20030118558 Lysin-deficient bacteriophages having reduced immunogenicity |
| 06/26/2003 | US20030118553 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and metastases mediated thereof |
| 06/26/2003 | US20030118551 Modified viral surface proteins for binding to extracellular matrix components |
| 06/26/2003 | US20030118549 Removal, contacting with interferon, reinsertion |
| 06/26/2003 | CA2470811A1 Protease inhibitors of the coagulation cascade isolated from dysidea sponges |
| 06/26/2003 | CA2470322A1 Methods for particle-assisted polynucleotide immunization using a pulsed electric field |
| 06/26/2003 | CA2469785A1 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor |
| 06/26/2003 | CA2469611A1 Cell constructs cultured in vitro, preparation and uses |
| 06/26/2003 | CA2464512A1 Outer membrane vesicles from gram negative bacteria and use as a vaccine |
| 06/25/2003 | EP1321526A2 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
| 06/25/2003 | EP1321516A2 Hydrogel matrix for cellular tissue storage |
| 06/25/2003 | EP1321152A1 Antidote for org 31540/SR 90107A |
| 06/25/2003 | EP1321150A1 Pharmaceutical composition for treatment of premature ejaculation and/or hypersensitivity of sexual stimulation |
| 06/25/2003 | EP1321143A1 Combination of N-butyldeoxygalactonojirimycin and glycolipid degrading enzyme in therapy |
| 06/25/2003 | EP1321122A1 Medicine and care product on basis of sourdough and process for its preparation |
| 06/25/2003 | EP1320752A2 Differential treatment of selected parts of a single cell with different fluid components |
| 06/25/2003 | EP1320621A2 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 06/25/2003 | EP1320603A1 Uses of the gjb6 gene for treating certain types of alopecia including the clouston's syndrome, and for screening compounds capable of being efficient in the treatment of alopecia with genetic susceptibility |
| 06/25/2003 | EP1320582A2 Adenovirus e1b-55k single amino acid mutants and methods of use |
| 06/25/2003 | EP1320581A1 T cell receptor transfer into a candidate effector cell or a precursor thereof |
| 06/25/2003 | EP1320545A2 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen |
| 06/25/2003 | EP1320379A2 Use of replication-deficient poxvirus vector to boost cd4+ t cell immune response to antigen |
| 06/25/2003 | EP1320371A2 Charged phospholipid compositions and methods for their use |
| 06/25/2003 | EP1320300A1 Food supplement |
| 06/25/2003 | EP1320292A2 Method of cloning porcine animals |
| 06/25/2003 | EP1112692B1 Drinks and foods capable of eliminating helicobacter pylori |
| 06/25/2003 | EP0980205B1 Use of a combination of tall-104 cells with adriamycin or cisplatin in the therapy of malignancies |
| 06/25/2003 | EP0707498B1 Implantable prosthesis, kit and device for manufacturing the same |
| 06/25/2003 | EP0679182B1 Delivery of gene products via mesangial cells |
| 06/25/2003 | CN2556947Y 珍珠胸罩 Pearl bra |
| 06/25/2003 | CN1426477A 方法 Method |
| 06/25/2003 | CN1426467A Thrombopoietin receptor modulating peptide |